Sign in to continue:

Thursday, April 30th, 2026

Sadot Group Inc. 2025 Annual Report: Business Overview, Strategic Shift, and Financial Highlights




Sadot Group Inc. 2025 Annual Report: Key Investor Takeaways

Sadot Group Inc. 2025 Annual Report: Key Points and Investor Insights

Overview and Company Background

Sadot Group Inc. (NASDAQ: SDOT), formerly known as Muscle Maker, Inc., operates in the “Retail-Eating & Drinking Places” sector and is incorporated in Nevada. The company’s headquarters are located at 295 E. Renfro Street, Suite 300, Burleson, Texas. The fiscal year ended on December 31, 2025, and this report covers audited operating and financial results for that period.

Key Financial and Corporate Highlights

  • Reverse Stock Splits: The company executed two 1-for-10 reverse stock splits, one effective October 18, 2024, and another on September 15, 2025, in order to maintain compliance with NASDAQ listing requirements. All share and per-share calculations in this report reflect these splits. Notably, shareholders who would have been entitled to fractional shares received cash in lieu. This is a major capital structure change and is likely to affect the market price per share.
  • Share Count and Public Float: As of April 28, 2026, Sadot Group had 1,835,668 shares outstanding. As of June 30, 2025, the market value of the company’s common stock held by non-affiliates (public float) was \$619,984. This relatively low public float may contribute to share price volatility.
  • Listing Status: Sadot Group’s common stock is listed on the NASDAQ Capital Market under the symbol “SDOT”. There are no other securities registered under Section 12(b) or 12(g) of the Exchange Act.
  • Filing Status: The company is a “smaller reporting company” and a “non-accelerated filer,” and is not an emerging growth company. It has filed all required reports in the past 12 months and is compliant with interactive data filing requirements.
  • Shell Company Status: Sadot Group is not a shell company.

Potentially Price-Sensitive Information for Shareholders

  • Reverse Stock Splits and Compliance: Two reverse splits within a year strongly indicate efforts to maintain NASDAQ compliance due to a low share price. While this action preserves listing status, it can also signal to the market that the company is under financial pressure or is experiencing share price weakness.
  • Capital Structure and Liquidity: The current low share count and public float may lead to higher volatility and lower liquidity, which can impact the ability of shareholders to buy/sell shares efficiently and can lead to larger price swings.
  • Absence of Restatements or Accounting Issues: There were no corrections of errors or restatements in the financial statements, and no recoveries of incentive compensation were triggered. The company is in compliance with all Sarbanes-Oxley requirements, though there is no attestation by an independent auditor regarding internal controls.
  • Pending or Potential Legal Proceedings: Investors should note that the annual report includes a section on legal proceedings, which could be material, but details are referenced to be found further in the report. Any adverse legal developments could impact the company’s financial position and stock price.

Corporate Governance and Reporting

  • Board and Executive Information: The report includes typical disclosures related to directors, executive officers, corporate governance, compensation, and accounting fees. There is no indication of unusual executive turnover, compensation issues, or governance crises in the summary.
  • Risk Factors and Forward-Looking Statements: The company provides a standard list of risk factors and forward-looking statement disclaimers. Investors are cautioned that projections and estimates are subject to uncertainty, and actual results may differ materially from expectations.

Key Sections for Investors to Review

Shareholders and potential investors are encouraged to read the following sections in detail:

  • Item 1A: Risk Factors
  • Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • Item 8: Financial Statements and Supplementary Data
  • Item 3: Legal Proceedings

These sections will provide the most insight into ongoing business risks, recent financial performance, and any pending litigation or regulatory matters.

Summary Table of Contents (Select Items)

Item Description Page
1 Business 4
1A Risk Factors 8
3 Legal Proceedings 27
7 Management’s Discussion and Analysis 36
8 Financial Statements 49

What May Move the Share Price?

  • Reverse Stock Splits: These are often interpreted as a sign of distress or attempts to maintain exchange listing. While they do not directly affect the company’s valuation, they can negatively impact investor sentiment and share price, at least in the short term.
  • NASDAQ Compliance: Maintaining listing is crucial for liquidity and access to capital. Any future risks of delisting would be highly material.
  • Legal and Regulatory Risks: Details on legal proceedings should be closely monitored for potential liabilities or settlements.
  • Low Public Float: The small public float can lead to significant volatility, both up and down, based on trading volume and news.

Conclusion

Investors in Sadot Group Inc. should closely monitor future filings and news releases for updates on legal proceedings, operational performance, and any further actions regarding NASDAQ compliance. The company’s capital structure changes and low public float are likely to keep the shares volatile. The absence of restatements or auditor issues is a positive, but the need for two reverse stock splits in quick succession is a red flag regarding historical share price performance.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult their financial advisor before making investment decisions. The information is based on the company’s SEC filings and may not reflect the most current developments.




View Sadot Group Inc. Historical chart here



Nektar Therapeutics Reports 2025 Financial Results and Advances Rezpegaldesleukin to Phase 3 for Atopic Dermatitis

Nektar Therapeutics Reports Q4 and Full Year 2025 Results: K...

CORVEX, INC. Files Form 8-K for Common Stock (MOVE) on NASDAQ – Company Details & Filing Summary

Corvex, Inc. Regains Compliance with Nasdaq’s Minimum Stockh...

WD-40 Company Q2 2026 Financial Report: Earnings, Net Income & Key Financials Highlights

WD-40 Company Q2 2026 Financial Results: Key Highlights and ...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today